---
date: "2024-03-20T00:00:00Z"
external_link: ""
image:
  caption: Rigshospitalet 
  focal_point: Smart
links:
- icon: linkedin
  icon_pack: fab
  name: Follow
  url: https://www.linkedin.com/posts/dr-andreas-venizelos-297802ab_medicalinnovation-cnsresearch-teamwork-activity-7182043471141060608-PMmO?utm_source=share&utm_medium=member_desktop
  
- icon: twitter
  icon_pack: fab
  name: Follow
  url: https://x.com/andvenizelos
  
summary:  Remarkable progress is happening at Rigshospitalet's Dept of Pathology! ðŸŽ‰ We're now performing rapid, in-depth CNS tumor classification during surgery, transforming patient care. ðŸ§ ðŸ’¥ A huge thank you to all who took part in our GridION Oxford Nanopore Technologies training. Let's keep advancing and shaping the future of healthcare! ðŸ’ª

tags:

title: Rigshospitalet Achieves Breakthrough in CNS Tumor Classification

---

Avantor/VWR is arranging a seminar day in Bergen focused on nanopore sequencing on September 26th (program). Participation is free and lunch is included! Get inspired by the latest technical updates from Oxford Nanopore Technologies as well as talks from local scientists in Western Norway about their latest nanopore projects. Additionally, the seminar day is a great opportunity to network and collaborate with other nanopore users in the area.

Register by emailing frida.perry@avantorsciences.com by September 15th.